首页> 美国卫生研究院文献>EMBO Reports >GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase
【2h】

GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase

机译:GyrI:一种针对蛋白质的DNA回旋酶抑制剂的反防御策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA gyrase is the target of two plasmid-encoded toxins CcdB and microcin B17, which ensure plasmid maintenance. These proteins stabilize gyrase–DNA covalent complexes leading to double-strand breaks in the genome. In contrast, the physiological role of chromosomally encoded inhibitor of DNA gyrase (GyrI) in Escherichia coli is unclear and its mechanism of inhibition has not been established. We demonstrate that the mode of inhibition of GyrI is distinct from all other gyrase inhibitors. It inhibits DNA gyrase prior to, or at the step of, binding of DNA by the enzyme. GyrI reduces intrinsic as well as toxin-stabilized gyrase–DNA covalent complexes. Furthermore, GyrI reduces microcin B17-mediated double-strand breaks in vivo, imparting protection to the cells against the toxin, substantiating the in vitro results. Thus, GyrI is an antidote to DNA gyrase-specific proteinaceous poisons encoded by plasmid addiction systems.
机译:DNA促旋酶是两种质粒编码毒素CcdB和microcin B17的靶标,可确保质粒维持。这些蛋白质稳定了促旋酶-DNA共价复合物,导致基因组中的双链断裂。相比之下,尚不清楚在大肠杆菌中染色体编码的DNA促旋酶(GyrI)抑制剂的生理作用,其抑制机理尚未建立。我们证明,GyrI的抑制模式不同于所有其他回旋酶抑制剂。它在酶与DNA结合之前或步骤抑制DNA促旋酶。 GyrI可减少内在的以及毒素稳定的回旋酶-DNA共价复合物。此外,GyrI在体内减少了microcin B17介导的双链断裂,为细胞提供了针对毒素的保护,从而证实了体外结果。因此,GyrI是由质粒成瘾系统编码的DNA促旋酶特异性蛋白质毒物的解毒剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号